Tag: PURE EP

BioSig Expands its Installation Base in Texas

Signs a new installation agreement with high-volume center in San Antonio Westport, CT, Nov. 04, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG […]

BioSig’s PURE EP System to be Featured in a Live Patient Case During Annual International Symposium on Ventricular Arrhythmias

Company’s signal processing technology for arrhythmia care to be featured during the event co-hosted by the University of Pennsylvania and The Mount Sinai Hospital Westport, CT, Oct. 12, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing […]

Clinical Data Acquired by the PURE EP™ System Published in the Journal of Cardiac Electrophysiology

The PURE EP™ System is validated in multi-center study as superior to conventional sources of intracardiac signals Westport, CT, Oct. 04, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and […]

BioSig Increases Installation Footprint Adding St. Elizabeth’s Medical Center to Roster of Premium Medical Institutions Utilizing the PURE EP System

The Company expands into exploration of its novel signal processing technology in physiologic pacing procedures Westport, CT, Sept. 13, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the […]

BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System

Westport, CT, May 04, 2021 (GLOBE NEWSWIRE) — The Company sees increased technology usage across its installed base and anticipates enrolling to at least 1500 cases by the end of 2021  44 physicians have conducted over 800 arrhythmia patient cases to date  Currently conducting patient cases in 9 medical centers […]

BioSig’s PURE EP(tm) System Evaluated with Patients at Mayo Clinic in Arizona

Westport, CT, April 27, 2021 (GLOBE NEWSWIRE) — The clinic is conducting an evaluation of the PURE EP(tm) System, a signal processing technology for cardiac arrhythmia treatments New installation follows Mayo Clinic in Florida that has been conducting patient cases with the technology since January 2020 BioSig Technologies, Inc. (NASDAQ: […]

BioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis Through its Electrophysiology Platform

Westport, CT, April 14, 2021 (GLOBE NEWSWIRE) — The latest release represents the most advanced software version of the PURE EPTM System, signal processing technology for treatments of irregular heartbeats BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve […]

BioSig lands Commercial Sales to Leading Hospital System

Westport, CT, April 06, 2021 (GLOBE NEWSWIRE) — World class healthcare institution adopts PURE EP™  across multiple States Medical centers resuming elective procedures helps drive sales acceleration BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal […]

BioSig PURE EP System Featured in the Editorial of EP Lab Digest

Westport, CT, Jan. 14, 2021 (GLOBE NEWSWIRE) — Leading industry publication calls attention to ongoing challenges in the electrophysiology lab PURE EP System is highlighted as a novel technological solution BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed […]

BioSig Conducts First Patient Cases with PURE EP(tm) System at Memorial Hospital of South Bend, Indiana

PURE EP(tm) system evaluation conducted under the leadership of Cardiologists Vinod Chauhan, M.D. and Deepak Gaba, M.D. Memorial Hospital is nationally recognized for its emphasis on innovation. Westport, CT, Jan. 12, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an […]